• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:掌跖皮疹的非感染性病因,需考虑的因素

Case Report: Non-infectious causes of palmoplantar rashes, what to consider.

作者信息

Advani Rashmi, Arad Danit

机构信息

Department of Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, 10467, USA.

出版信息

F1000Res. 2018 Jan 11;7:46. doi: 10.12688/f1000research.13513.1. eCollection 2018.

DOI:10.12688/f1000research.13513.1
PMID:29568490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5840616/
Abstract

Palm and sole skin eruptions have a broad differential diagnosis. It is particularly important to recognize common causes as well as their association with certain chemotherapy regimens such as Capecitabine. A 79-year-old woman presented with a painful rash on her hands and feet for 1 week. She had metastatic colon cancer and was in her third week of treatment with capecitabine. Her diagnosis was a medication side-effect from chemotherapy. Capecitabine was stopped and she had some clinical improvement over the next two days. She was discharged with oncology follow up for resumption of Capecitabine at a lower dose with improvement in her rash 3 weeks later.
 Skin rashes are a commonly encountered complaint in patients in the inpatient and outpatient setting. It is important to maintain a broad differential diagnosis in those with rashes of the palmoplantar surfaces of the hands and feet. Recognizing skin changes as a possible manifestation of underlying malignancy or a medication side-effect is key in appropriate diagnosis and treatment.

摘要

手掌和足底皮肤疹有广泛的鉴别诊断。识别常见病因以及它们与某些化疗方案(如卡培他滨)的关联尤为重要。一名79岁女性因手脚疼痛性皮疹就诊1周。她患有转移性结肠癌,正处于卡培他滨治疗的第三周。她的诊断为化疗药物副作用。停用卡培他滨后,接下来两天她的症状有了一些改善。她出院时接受肿瘤学随访,3周后以较低剂量恢复使用卡培他滨,皮疹有所改善。皮肤疹是住院和门诊患者常见的主诉。对于手脚掌跖表面有皮疹的患者,保持广泛的鉴别诊断很重要。认识到皮肤变化可能是潜在恶性肿瘤或药物副作用的表现是正确诊断和治疗的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829f/5840616/28b12be206b9/f1000research-7-14673-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829f/5840616/c4e44313c129/f1000research-7-14673-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829f/5840616/28b12be206b9/f1000research-7-14673-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829f/5840616/c4e44313c129/f1000research-7-14673-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829f/5840616/28b12be206b9/f1000research-7-14673-g0001.jpg

相似文献

1
Case Report: Non-infectious causes of palmoplantar rashes, what to consider.病例报告:掌跖皮疹的非感染性病因,需考虑的因素
F1000Res. 2018 Jan 11;7:46. doi: 10.12688/f1000research.13513.1. eCollection 2018.
2
Photosensitive lichenoid skin reaction to capecitabine.卡培他滨致光敏性苔藓样皮肤反应。
BMC Cancer. 2017 Dec 19;17(1):866. doi: 10.1186/s12885-017-3882-4.
3
Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?一名服用卡培他滨的患者出现硬皮病:这是手足综合征的一种变体吗?
Cureus. 2016 Jun 30;8(6):e663. doi: 10.7759/cureus.663.
4
Paraneoplastic Scleroderma: Are There Any Clues?副肿瘤性硬皮病:有什么线索吗?
Acta Dermatovenerol Croat. 2016 Apr;24(1):78-80.
5
[A case of palmoplantar dysesthesia syndrome caused by capecitabine].[一例由卡培他滨引起的手足感觉异常综合征]
Agri. 2016 Jan;28(1):54-6. doi: 10.5505/agri.2014.32559.
6
Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.单侧手足综合征:卡培他滨的一种罕见副作用。
Cutan Ocul Toxicol. 2010 Jun;29(2):140-2. doi: 10.3109/15569521003699585.
7
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].[一名14岁女孩的紧张症:氯硝西泮和卡马西平治疗及10年随访]
Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. Epub 2009 May 12.
8
Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.
Ann Pharmacother. 2009 Jul;43(7):1370-3. doi: 10.1345/aph.1M120. Epub 2009 Jul 7.
9
Flagellate Rash: An Unusual Complication of Bleomycin Therapy - A Case Report with Brief Review of Literature.鞭毛虫疹:博来霉素治疗的一种罕见并发症——病例报告及文献综述
Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):548-551. doi: 10.4103/ijmpo.ijmpo_147_16.
10
Rash Decisions: An Approach to Dangerous Rashes Based on Morphology.仓促的决策:基于形态学的危险皮疹处理方法
J Emerg Med. 2017 Apr;52(4):457-471. doi: 10.1016/j.jemermed.2016.10.027. Epub 2016 Nov 29.

引用本文的文献

1
Beware the Unexpected Infection: Disseminated Varicella Zoster Virus Mimicking A Drug Eruption.当心意料之外的感染:播散性水痘带状疱疹病毒酷似药物疹。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221117785. doi: 10.1177/23247096221117785.

本文引用的文献

1
Incidence and implications of chemotherapy related hand-foot syndrome.化疗相关手足综合征的发生率及影响
Expert Opin Drug Saf. 2016 Dec;15(12):1625-1633. doi: 10.1080/14740338.2016.1238067. Epub 2016 Oct 8.
2
Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.吡哆醇预防卡培他滨治疗相关性手足综合征的疗效:一项随机、双盲、安慰剂对照研究的结果。
J Clin Oncol. 2010 Aug 20;28(24):3824-9. doi: 10.1200/JCO.2010.29.1807. Epub 2010 Jul 12.
3
Cutaneous manifestations of internal malignancy.
内脏恶性肿瘤的皮肤表现
Curr Probl Surg. 2010 May;47(5):384-445. doi: 10.1067/j.cpsurg.2010.01.003.
4
Acquired ichthyosis as a paraneoplastic syndrome in Hodgkin's disease.获得性鱼鳞癣作为霍奇金病的副肿瘤综合征。
Clin Transl Oncol. 2009 Aug;11(8):552-3. doi: 10.1007/s12094-009-0402-2.
5
Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature.黑棘皮病作为一种副肿瘤综合征。病例报告及文献综述。
Pol Arch Med Wewn. 2009 Mar;119(3):180-3.
6
Cutaneous manifestations of internal malignancy.内脏恶性肿瘤的皮肤表现
CA Cancer J Clin. 2009 Mar-Apr;59(2):73-98. doi: 10.3322/caac.20005. Epub 2009 Mar 3.
7
Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.抗肿瘤治疗引起的手足红斑感觉异常综合征(“手足”综合征)。发病率、识别与管理。
Am J Clin Dermatol. 2000 Jul-Aug;1(4):225-34. doi: 10.2165/00128071-200001040-00004.
8
Tripe palms and malignancy.掌跖角化瘤与恶性肿瘤。
J Clin Oncol. 1989 May;7(5):669-78. doi: 10.1200/JCO.1989.7.5.669.